Cat Number: API910463682

Semaglutide

CAS Number

910463-68-2

Description

Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. On Oct 18, 2017, Novo Nordisk received positive 16-0 vote from FDA Advisory Committee in favor of approval for Semaglutide.

Molecular Weight

4114

Molecular Formula

C187H291N45O59

EINECS

691-729-9

Appearance

White to almost white powder

Standard

In-house/Commerical
Facility GMP

Qualification

USMF/ASMF/CDE/DMF/CEP/NMPA/FDA/WC